HighTower Advisors »

Denali Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $858k 40k 21.65
2023-09-30 $1.1M 54k 20.74
2023-06-30 $1.6M 55k 29.55
2023-03-31 $1.2M 52k 23.05
2022-12-31 $623k 22k 28.05
2022-09-30 $573k 19k 30.44